Ketamine Nasal Spray vs. Troches vs. Infusions: Which Delivery Method Fits Your Treatment Goals?

Ketamine therapy is not a one-size-fits-all treatment. The same medication can feel very different depending on how it enters the body, how quickly it reaches the bloodstream, and how precisely the dose can be adjusted. Ketamine nasal spray, troches, and intravenous (IV) infusions each have distinct advantages and limitations.

So, which option makes the most sense for your treatment goals? The answer depends on factors such as how quickly you need an effect, how comfortable you are with clinical visits, how much dosing flexibility is needed, and whether treatment is designed for supervised or home-based care.

Here’s a blog comparing each of the methods.

How Does Each Ketamine Delivery Method Work?

The route of administration influences how much medication reaches circulation and how quickly it gets there.

• IV ketamine infusions deliver the medication directly into the bloodstream, bypassing absorption barriers in the digestive system. This makes IV administration highly controllable and one of the most extensively studied ketamine approaches for depression. Antidepressant effects can emerge within hours, with benefits often peaking around 24 hours after treatment.
• Ketamine nasal spray uses the nasal mucosa for absorption, allowing the medication to enter circulation without relying entirely on the gastrointestinal tract.
• Ketamine troches dissolve in the mouth, allowing medication to be absorbed through oral mucosal tissues. Some medication may still be swallowed and undergo first-pass metabolism, meaning absorption can be more variable than with IV administration. Research on oral and sublingual ketamine suggests that individual differences in absorption can make dose adjustment particularly important.

Which Method Works Fastest?

When rapid delivery and highly predictable dosing are priorities, IV infusion has an important advantage. As the medication enters the bloodstream directly, clinicians can adjust the infusion while monitoring the patient’s response.

Research examining IV ketamine for treatment-resistant depression has found meaningful effects as early as four hours after treatment, with effects remaining detectable for several days.

Nasal administration also provides relatively rapid absorption. However, ketamine nasal spray should not automatically be considered interchangeable with FDA-approved intranasal esketamine. The medications, formulations, dosing protocols, and regulatory status can differ.

Ketamine troche therapy generally offers a less immediate route. Its appeal is often less about achieving the fastest possible onset and more about convenience, flexibility, and suitability for a treatment plan that does not require an infusion chair.

Who May Prefer Each Route?

• IV infusions:These may appeal to patients who need the highest degree of clinical supervision and precise dose control. They also make sense when rapid delivery is a central treatment consideration. Because IV ketamine can affect blood pressure, heart rate, perception, and alertness, clinical monitoring is important.
• Nasal spray:This route may suit patients who prefer a non-invasive administration method and want something faster and more straightforward than an infusion. However, medical supervision and eligibility requirements depend on the specific medication and protocol.
• Troches:These may be attractive to patients who prioritize convenience and want a medication format that can fit into a structured ketamine therapy from home Oral and sublingual approaches also allow clinicians to individualize dosing over time, although absorption can be less predictable than IV delivery.

Is At-Home Ketamine Therapy Right for Everyone?

Convenience should never be the only deciding factor. Ketamine can cause dissociation, sedation, increases in blood pressure, dizziness, and other effects, and its longer-term risks are still being studied.

A structured home program may therefore include medical screening, individualized prescribing, instructions for administration, clinician communication, and integration or follow-up support. The goal is not simply to make treatment available outside a clinic; it is to create an appropriate framework around the treatment.

The best delivery method is ultimately the one that balances treatment goals, comfort, dosing needs, and appropriate clinical support. Convenience matters, but so does having a structured plan that accounts for how each person responds to treatment.

For qualified patients who prefer care from home, Daytryp RX provides clinician-led telehealth ketamine therapy with both ketamine troche therapy and nasal spray options. Our at-home program includes an initial medical consultation, medication delivered to the patient, optional provider follow-ups, integration support, and ongoing access to the care team.

Considering home-based ketamine treatment? Contact us today to connect with the care team that prioritizes your treatment goals.

Search Berg

See Full Bio